5 days ago · 6.9%. Market Average Movement. 4.9%. 10% most volatile stocks in GB Market. 11.1%. 10% least volatile stocks in GB Market. 2.5%. Stable Share Price: 0JBU has not had significant price volatility in the past 3 months. Volatility Over Time: 0JBU's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks. Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.Summary Volume and Price by Trading Session for NTLA ; Prev Close, 28.47, 27.47 ; Premarket VWAP, 28.06, 27.47 ; Open Cross, 27.59, 27.47 ; Regular Hours VWAP ...NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.The Intellia Therapeutics Inc ( NTLA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $35.09, representing a +29.23% increase from the current price of $27.15. The highest analyst price target is $39.38, and the lowest is $30.80. Based on our technical indicators, the current sentiment ...5 days ago · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Wall Street expects a year-over-year decline in earnings on higher revenues when Intellia Therapeutics, Inc. (NTLA Quick Quote NTLA - Free Report) reports results for the quarter ended December ...Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.Intellia Therapeutics, Inc. (NTLA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks.According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...NTLA Intellia Therapeutics Inc. BPC Chart Overview 03/28/22 Intellia Therapeutics Inc. NASDAQ: NTLA Chart Overview 03/28/22 Intellia is trading in a 9-month downward channel pullback, closing the gap created by the release of Phase 1 data of NTLA-2001 to treat ATTR. The release caused a bull pennant that led to a reversal into a downward channel. Yet despite these upgrades, the analysts cut their price target 8.0% to US$76.36, implicitly signalling that the ongoing losses are likely to weigh negatively on Intellia Therapeutics' valuation.Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. The latest closing stock price for Intellia Therapeutics as of January 05, 2024 is 28.63. The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021. The Intellia Therapeutics 52-week high stock price is 47.48, which is 65.8% above the current share price. The Intellia Therapeutics 52-week low stock price is 22 ... Feb 9, 2024 · MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023. Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 22, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.26. Intellia Therapeutics Inc is up 6.32% from its previous closing price of $28.46. During the last market session, Intellia Therapeutics Inc’s stock traded between $28.43 and $29.84.The average price target for Intellia Therapeutics is $72.29. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $95.00 ,the lowest forecast is $49.00. The average price target represents 173.31% Increase from the current price of $26.45.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.The above is based on 19 Wall Street analysts offering 12-month price targets for Intellia in the last 3 months. The average price target is $173.11 with a high forecast of $238.00 and a low ...Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...Feb 17, 2024 · Wall Street analysts are quite bullish about Intellia Therapeutics (NASDAQ: NTLA) stock. On average, they're estimating that it'll rise by around 157% within the next …Trefis Estimates Intellia Therapeutics Valuation At $26.00 Per Share · Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate · [1] Price To Sales ...Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Get the latest Intellia Therapeutics Inc. (NTLA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.30 Jan 2024 ... Intellia Therapeutics Inc is down 6.07% from its previous closing price of $26.18. During the last market session, Intellia Therapeutics Inc's ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.5 days ago · With Intellia Therapeutics stock trading at $27.15 per share, the total value of Intellia Therapeutics stock (market capitalization) is $2.43B. Intellia Therapeutics stock was originally listed at a price of $22.10 in May 6, 2016. If you had invested in Intellia Therapeutics stock at $22.10, your return over the last 7 years would have been 22. ... See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ... Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics. By Alex Carchidi – Jan 21, 2024 at 8:00AM ... Current Price. $27.18. Price as of February 22, 2024, 4:00 p.m. ET.3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, …Intellia Therapeutics Inc (0JBU.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics Inc | CINNOBER BOAT: 0JBU ...The Intellia Therapeutics stock forecast for tomorrow is $ 27.15, which would represent a -2.12% loss compared to the current price. In the next week, the price of NTLA is expected to decrease by -2.51% and hit $ 27.04.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently …Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.Wondering where to invest your money? Compare real estate vs. stocks and find the most profitable investment for your financial situation. Compare real estate vs. stocks and find t...12 hours ago · Intellia Therapeutics price target lowered to $64 from $78 at Guggenheim Intellia Therapeutics price target raised to $73 from $72 at Canaccord Intellia Therapeutics reports Q4 EPS ($1.46 ... NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating Nov. 10: MT Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3 ... Stock Intellia Therapeutics, Inc. …Analyst Salveen Richter from Goldman Sachs downgraded the rating on the stock to a Hold and gave it a $32.00 price target. Intellia Therapeutics (NTLA) is a company developing gene editing-based therapies. The timeline for significant events in the company's pipeline stretches into 2024 and beyond.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.3 days ago · Intellia Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Feb 21, 2024 6:22 a.m. EST Delayed quote $ 27.27 0.12 0.44% Before Hours Volume: 480 Advanced Charting... View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.The Vanguard Group, Inc. is the second largest shareholder owning 9.2% of common stock, and BlackRock, Inc. holds about 9.1% of the company stock. Furthermore, CEO John Leonard is the owner of 0.9 ...Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …Analyst's Opinion · Consensus Rating. Intellia Therapeutics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis. Jan 18, 2024 · Intellia Therapeutics, Inc. (NTLA Quick Quote NTLA - Free Report) is a clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. View Intellia Therapeutics (NTLA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.5 May 2016 ... Intellia's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "NTLA" on May 6, 2016 . Credit Suisse , ....See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 26.10-1. ...Intellia Therapeutics Stock Price Prediction 2024, 2025 - 2028. Moderna Price Prediction Tomorrow & Month. In 2 weeks Intellia Therapeutics stock prediction on Thursday, February, 22: 26.39 dollars, maximum 28.50, minimum 24.28. Intellia Therapeutics stock price forecast on Friday, February, 23: 25.64 dollars, maximum 27.69, minimum 23.59.Intellia Therapeutics Inc’s ( NTLA) price is currently up 14.81% so far this month. During the month of November, Intellia Therapeutics Inc’s stock price has reached a high of $29.02 and a low of $24.38. Over the last year, Intellia Therapeutics Inc has hit prices as high as $57.49 and as low as $22.81. Year to date, Intellia Therapeutics ...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you... 12 hours ago · Intellia Therapeutics price target lowered to $64 from $78 at Guggenheim Intellia Therapeutics price target raised to $73 from $72 at Canaccord Intellia Therapeutics reports Q4 EPS ($1.46 ... 4 days ago · Feb. 15. MT. Morgan Stanley Adjusts Intellia Therapeutics' Price Target to $85 From $90, Keeps Overweight Rating. Nov. 13. MT. Oppenheimer Slashes Price Target on Intellia Therapeutics to $70 From $80, Maintains Outperform Rating. Nov. 13. MT. Goldman Sachs Adjusts Price Target on Intellia Therapeutics to $136 From $157, Maintains Buy Rating. Analyst's Opinion · Consensus Rating. Intellia Therapeutics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to ...Get the latest Intellia Therapeutics Inc (38I) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Intellia Therapeutics stock rose 15% over a five-day trading period ending 3/16/2021, compared to a broader market (S&P500) rise of 2.6%. A change of 15% or more over five trading days is a 9% ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Intellia Therapeutics Stock Forecast, NTLA stock price prediction. Price target in 14 days: 30.739 USD. The best long-term & short-term Intellia ...Intellia Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! NTLA forecast for the upcoming days Date Price Min Price Max Price; 2024-02-26: Price: 26.742: Min: 25.357: Max: ...If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Intellia Therapeutics, Inc. (NTLA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks.View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN. See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ... These 4 analysts have an average price target of $80.75 versus the current price of Intellia Therapeutics at $23.64, implying upside. Below is a summary of how these 4 analysts rated Intellia ...Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...Analyst Salveen Richter from Goldman Sachs downgraded the rating on the stock to a Hold and gave it a $32.00 price target. Intellia Therapeutics (NTLA) is a company developing gene editing-based therapies. The timeline for significant events in the company's pipeline stretches into 2024 and beyond.CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some early-stage research.. The cuts come a little over three months after Intellia, one of the first companies founded to turn the gene editing technology into medicines, received a green light from U.S. regulators to begin a late …NTLA Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $79.21 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 186.27% change from the last price of $27.67. Intellia’s stock jumps as CRISPR therapy moves into Phase 2 clinical trial MarketWatch. Friday, January 06, 2023. 07:49 AM ET. Intellia Therapeutics stock price target cut to $131 from $173 at Stifel Nicolaus MarketWatch. Tuesday, October 11, 2022. 09:41 AM ET. Intellia Therapeutics started at overweight with $84 stock price target at …Intellia Therapeutics, Inc. Stock price Börse Stuttgart Equities 38I US45826J1051 Biotechnology & Medical Research Real-time Estimate ...
View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN. . Pushin p
Intellia Therapeutics stock prediction for May 2025. The forecast for beginning 52.37 dollars. Maximum price 58.68, minimum 49.98. Averaged Intellia Therapeutics stock price for the month 53.84. At the end 54.33 dollars, change for May 3.7%. Intellia Therapeutics stock price forecast for June 2025.For instance, Wall Street analysts are currently predicting that shares of the gene editing therapy biotech Intellia Therapeutics (NTLA-2.56%) will rise by 107% to reach a price of more than $87 ...29 Dec 2023 ... About Intellia Therapeutics Inc (NTLA). Before we jump into Intellia Therapeutics Inc's stock price, history, target price and what caused it to ...Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …NTLA has a greater number of analysts covering the stock than 7231.16% of all US stocks. In terms of how INTELLIA THERAPEUTICS INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 7640.16% of that group.View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.May 24, 2002 · Real-time Price Updates for Intellia Thera CS (NTLA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...Feb 9, 2024 · MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023. MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. Intellia Therapeutics Inc (0JBU.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics Inc | CINNOBER BOAT: 0JBU ...Analyst Salveen Richter from Goldman Sachs downgraded the rating on the stock to a Hold and gave it a $32.00 price target. Intellia Therapeutics (NTLA) is a company developing gene editing-based therapies. The timeline for significant events in the company's pipeline stretches into 2024 and beyond.RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT ... Stock Intellia Therapeutics, Inc. - Nasdaq . News Intellia Therapeutics, Inc. Transcript : Intellia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05 ...Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Jan 21, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them. The 10 stocks that ... You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price..